Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Cerilliant
Fuji
AstraZeneca
Cipla
Chinese Patent Office
Colorcon
Dow
Farmers Insurance

Generated: April 25, 2018

DrugPatentWatch Database Preview

CLOMIPRAMINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

When do Clomipramine Hydrochloride patents expire, and what generic alternatives are available?

Clomipramine Hydrochloride is a drug marketed by Mylan, Sandoz, Taro, Teva, Watson Labs, and Zydus Pharms Usa Inc. and is included in nine NDAs.

The generic ingredient in CLOMIPRAMINE HYDROCHLORIDE is clomipramine hydrochloride. There are ten drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the clomipramine hydrochloride profile page.
Drug patent expirations by year for CLOMIPRAMINE HYDROCHLORIDE
Pharmacology for CLOMIPRAMINE HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for CLOMIPRAMINE HYDROCHLORIDE
Synonyms for CLOMIPRAMINE HYDROCHLORIDE
(3-{5-CHLORO-2-AZATRICYCLO[9.4.0.0(3),?]PENTADECA-1(15),3,5,7,11,13-HEXAEN-2-YL}PROPYL)DIMETHYLAMINE HYDROCHLORIDE
(3-{5-chloro-2-azatricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaen-2-yl}propyl)dimethylamine hydrochloride
(non-labelled)Clomipramine-13C-d3 HCl
1-(2,4-Dichloro-|A-[(2,4-dichlorobenzyl)oxy]phenethyl)imidazole
17321-77-6
2LXW0L6GWJ
3-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethyl-propan-1-amine hydrochloride
3-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethylpropan-1-amine hydrochloride
3-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethylpropan-1-amine;hydrochloride
3-(3-CHLORO-10,11-DIHYDRO-5H-DIBENZO[B,F]AZEPIN-5-YL)-N,N-DIMETHYLPROPAN-1-AMINE HCL
3-(3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine hydrochloride
3-(3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-aminium chloride
3-Chloro-10,11-dihydro-N,N-di- methyl-5H-dibenz[b,f]azepine-5-propanamine hydrochloride
3-Chloro-10,11-dihydro-N,N-di-methyl-5H-dibenz[b,f]azepine-5-propanamine hydrochloride
3-Chloro-10,11-dihydro-N,N-dimethyl-5H-dibenz(Z)[b,f]azepine-5-propanamine hydrochloride
3-Chloro-5-(3-(dimethylamino)propyl)-10,11-dihydro-5H-dibenz(b,f)azepine monohydrochloride
3-chloro-5-[3-(dimethylamino)propyl]-10,11-dihydro-5H-dibenz[b,f]azepine monohydrochloride
3-Chloroimipramine hydrochloride
303-49-1 (Parent)
321C776
5H-Dibenz(b,f)azepine-5-propanamine, 3-chloro-10,11-dihydro-N,N-dimethyl-, monohydrochloride
5H-Dibenz(b,f)azepine, 10,11-dihydro-3-chloro-5-(3-(dimethylamino)propyl)-, monohydrochloride
5H-Dibenz(b,f)azepine, 10,11-dihydro-3-chloro-5-(3-(dimethylamino)propyl)-,monohydrochloride
AB0013787
AB1009567
AC-8082
AC1L29YA
AC1Q3BC4
AK-63496
AKOS015895084
AN-8372
Anafranil
Anafranil hydrochloride
Anafranil hydrochloride; Chloripramine
Anaphranil
ANW-66321
API0002068
AX8041370
BB_SC-4136
BC251905
C 7291
C19H23ClN2.HCl
C19H24Cl2N2
CAS-17321-77-6
CCG-39492
CHEBI:3755
CHEMBL1200710
Chlorimipramine hydrochloride
Chloroimipramine monohydrochloride
Clomicalm
Clomipramine (hydrochloride)
Clomipramine HCL
Clomipramine Hydochloride
Clomipramine hydrochloride (Anafranil)
Clomipramine hydrochloride (JP17/USP)
Clomipramine hydrochloride [USAN:JAN]
Clomipramine hydrochloride [USAN:USP:JAN]
Clomipramine Hydrochloride 1.0 mg/ml in Methanol (as free base)
Clomipramine hydrochloride, >=98% (HPLC), powder
Clomipramine hydrochloride, for microbiological assay, European Pharmacopoeia (EP) Reference Standard
Clomipramine hydrochloride, pharmaceutical secondary standard; traceable to USP, PhEur, BP
Clomipramine hydrochloride, United States Pharmacopeia (USP) Reference Standard
Clomipramine Monohydrochloride
CPD000058295
CS-2568
CTK8C1351
D00811
D05AAW
DSSTox_CID_22633
DSSTox_GSID_42633
DSSTox_RID_80064
DTXSID3042633
EINECS 241-344-3
EU-0100307
FT-0623989
G-34586
HMS1568F20
HY-B0457
I06-0497
I615
J10410
KS-00000XL9
KS-00002WV3
KS-1044
LP00307
LS-173091
LS-60387
MFCD00069234
MLS-0090819.0001
MLS000028511
MLS001074205
MLS002222159
MLS002548879
MolPort-000-917-725
NC00678
NCGC00093756-01
NCGC00093756-02
NCGC00093756-03
NCGC00093756-04
NCGC00178275-01
NCGC00178275-02
NCGC00255897-01
NCGC00260992-01
NSC-759323
NSC759323
Opera_ID_368
Pharmakon1600-02300061
PL006876
Premature ejaculation therapy (inhaled, PowerHale), Vectura
Prestwick_72
PubChem21396
REGID_for_CID_68539
s2541
SAM002264601
SC-18841
SCHEMBL41747
SMR000058295
SPECTRUM2300061
SR-01000003088
SR-01000003088-2
SR-01000003088-5
ST24041426
ST51014962
TC-155066
Tox21_301819
Tox21_500307
UNII-2LXW0L6GWJ
VR-776

US Patents and Regulatory Information for CLOMIPRAMINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan CLOMIPRAMINE HYDROCHLORIDE clomipramine hydrochloride CAPSULE;ORAL 074947-001 Apr 30, 1998 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Teva CLOMIPRAMINE HYDROCHLORIDE clomipramine hydrochloride CAPSULE;ORAL 074958-003 Aug 26, 1997 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs CLOMIPRAMINE HYDROCHLORIDE clomipramine hydrochloride CAPSULE;ORAL 074751-003 Sep 30, 1998 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sandoz CLOMIPRAMINE HYDROCHLORIDE clomipramine hydrochloride CAPSULE;ORAL 074953-002 Jun 25, 1997 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Mallinckrodt
Fish and Richardson
US Army
Chinese Patent Office
Fuji
McKesson
Merck
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.